Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Radnostix

US Class II Ongoing · initiated 2026-01-26

Presence of Particulate Matter: Due to production issues

Unichem Pharmaceuticals USA Inc.

US Class II Ongoing · initiated 2026-01-21

cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.

Unichem Pharmaceuticals USA Inc.

US Class III Ongoing · initiated 2026-01-21

Tablets/Capsules Imprinted with Wrong ID

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

ACME UNITED CORPORATION

US Class II Ongoing · initiated 2026-01-20

CGMP Deviations

BiOptimizers Magnesium Breakthrough capsules

Canada Type III Ongoing · initiated 2026-01-19

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…